Robert D. Allen III, Chief Scientific Officer at Invivyd, Inc. (IVVD), sold 45,932 shares at $0.57 ($28K) on 2025-08-19, disclosed to the SEC on 2025-08-19.
Scheduled sale ($28k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.65 | 18,512 | $12K | 43.5% |
| 2 | $0.57 | 27,420 | $16K | 56.5% |
| Total | $0.60 avg | 45,932 | $28K | 100% |
| Filing → |